Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hilton Becker

Boca Raton, FL Medical Doctor

NPI 1467672139 CMS profile 112253

670 Glades Rd, Suite 220, Boca Raton, FL 33431

Open in the dashboard

General payments

$514,896

85 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Hilton Becker of Boca Raton, FL is reported in the CMS Open Payments database as having received $514,896 across 85 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $67,274 16
2024 General $64,372 10
2023 General $64,745 16
2022 General $48,816 11
2021 General $79,933 11
2020 General $80,264 10
2019 General $109,493 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hilton Becker
  • Florida median
  • Middle half of Florida
  • National median

In program year 2025, general payments to Hilton Becker were reported at $67,274. Among 84,641 Florida profiles paid that year, the median was $195 and the middle half received between $59 and $690.

Show as a table
Year Hilton Becker Florida median Middle half National median
2019 $109,493 $197 $63–$719 $163
2020 $80,264 $126 $38–$436 $114
2021 $79,933 $151 $45–$537 $132
2022 $48,816 $175 $53–$607 $149
2023 $64,745 $183 $57–$637 $160
2024 $64,372 $185 $56–$647 $164
2025 $67,274 $195 $59–$690 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Mentor Worldwide LLC $512,757 51 payments
  2. Integra LifeSciences Corporation $629 5 payments
  3. TELA Bio, Inc. $305 8 payments
  4. Allergan Inc. $204 2 payments
  5. Innovation Technologies Inc $170 1 payment
  6. Kerecis Limited $150 1 payment
  7. AcelRx Pharmaceuticals, Inc. $126 2 payments
  8. RTI Surgical, Inc $124 1 payment
  9. Baxter Healthcare $106 1 payment
  10. Davol Inc. $100 1 payment
  11. Other $226 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $510,219 29 payments
  2. Food and Beverage $2,727 51 payments
  3. Travel and Lodging $1,314 3 payments
  4. Long term medical supply or device loan $326 1 payment
  5. Gift $310 1 payment
Products named General payments · program years 2019–2025
  1. SILTEX Breast Implants $254,884 13 payments
  2. MENTOR MemoryGel Breast Implant $126,472 7 payments
  3. MENTOR CPX 2 Breast Tissue Expander $1,644 9 payments
  4. DuraSorb Monofilament Mesh $346 2 payments
  5. MENTOR MemoryGel Resterilizable Gel Sizer $320 8 payments
  6. Integra Recon-Skin And Wound $283 3 payments
  7. Integra Recon-Skin And Wound $283 3 payments
  8. INTEGRA DERMAL REGENERATION TEMPLATE $283 3 payments
  9. MemoryGel Breast Implants $278 5 payments
  10. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $275 7 payments
  11. Other $1,761 25 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

85 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record